All questions are shown as received by the Trust.
In the past 3 months [latest 3 months available] how many patients have received the following treatments [for any disease]:
1. Berinert (Human C1-esterase inhibitor)
2. Cinryze (Human C1-esterase inhibitor)
3. Orladeyo (berotralstat)
4. Takhzyro (Lanadelumab)
5. Ruconest (Recombinant human C1-esterase inhibitor)
6. Firazyr (Icatibant)
7. Icatibant – any brand except Firazyr
Treatments for any disease.230823.docx
